DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Celsion Corporation (CLSN)
« Back to company indexCLSN Chatter Timeline
Stock Ticker for CLSN
Most Active Tweeters for CLSN
| User | Tweets |
|---|---|
| @TranscriptDaily | 2 |
| @TheMarketsDaily | 2 |
| @ThisLincolnian | 1 |
| @dailypoliticaln | 1 |
| @Markfor65836606 | 1 |
Recent Tweets for CLSN
 |
@SolarMelt $CLSN Sentiment positive for the first time since May 16th. First efficacy interim analysis for OPTIMA, a P3 trial… https://t.co/QbmcO5av18 July 14th 2019, 10:07pm |
 |
@TranscriptDaily Celsion $CLSN Downgraded to Sell at Zacks Investment Research https://t.co/S657sbyZCc July 12th 2019, 4:07am |
 |
@dispatchtribune Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/lgD3zz9F53 July 11th 2019, 7:07pm |
 |
@OlympiaReport Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/iRr3Mdz9QV July 11th 2019, 7:07pm |
 |
@Markfor65836606 $CLSN signs of life. If you are not in this it certainly would be worth a gamble just before they announced the first interim efficacy. July 10th 2019, 10:07am |
 |
@TheMarketsDaily Celsion $CLSN Stock Price Crosses Above Fifty Day Moving Average of $1.91 https://t.co/2Xwpuz34tc July 10th 2019, 9:07am |
 |
@ThisLincolnian Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/5r3Qe6AZki July 10th 2019, 3:07am |
 |
@WeekHerald Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/pm8KsjErDC July 10th 2019, 3:07am |
 |
@TickerReport Celsion $CLSN Lowered to “Sell” at Zacks Investment Research https://t.co/vVmmDAuEY6 July 9th 2019, 4:07am |
 |
@ZolmaxNews Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/Y2LxlS976Z July 5th 2019, 8:07am |
 |
@midetimes Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/NvgReHmJNA #stocks July 5th 2019, 8:07am |
 |
@dailymailtimes Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/jsTktx1vqO #investing July 5th 2019, 8:07am |
 |
@dailypoliticaln Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/nZlkLN6XaO July 5th 2019, 8:07am |
 |
@WatchlistN Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/7G5j9VyA0I July 5th 2019, 8:07am |
 |
@storminvestor Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/NiqgXtLktd #markets July 4th 2019, 4:07am |
 |
@stocknewstimes Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/EqiOGOv9WG July 4th 2019, 4:07am |
 |
@SleekMoneycom Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/ptO7McKP3t #investing July 4th 2019, 4:07am |
|
@TheMarketsDaily Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/dliopHIhwL July 4th 2019, 4:07am |
|
@TranscriptDaily Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/UhwiynZNu7 July 4th 2019, 4:07am |
 |
@WKRBNews Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/zrhcjfiX1S #markets June 29th 2019, 6:06am |
|
@dakotafinancial Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/bI1pllNiwL June 29th 2019, 6:06am |
|
@WeekHerald Celsion $CLSN Cut to Sell at Zacks Investment Research https://t.co/1UNz9jKuZe June 28th 2019, 5:06am |
|
@ThisLincolnian Celsion $CLSN Rating Lowered to Sell at Zacks Investment Research https://t.co/JZF9tmUuIe June 28th 2019, 5:06am |
|
@TickerReport Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/qIk87oyCGO June 27th 2019, 1:06am |
|
@stocknewstimes Celsion $CLSN Stock Rating Lowered by Zacks Investment Research https://t.co/g76TvJiT56 June 27th 2019, 1:06am |
|
@SleekMoneycom Celsion $CLSN Stock Rating Lowered by Zacks Investment Research https://t.co/E896742oAZ #investing June 27th 2019, 1:06am |
|
@storminvestor Celsion $CLSN Stock Rating Lowered by Zacks Investment Research https://t.co/ankdDxA8QD #markets June 27th 2019, 1:06am |
 |
@StockTipRobot Listen humans, you should quit your job and buy Celsion $CLSN #BullMarket June 25th 2019, 3:06pm |
|
@WKRBNews Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/RL0lC9EBYf #markets June 23rd 2019, 7:06am |
|
@dakotafinancial Zacks Investment Research Downgrades Celsion $CLSN to Sell https://t.co/dHUmsqiG5N June 23rd 2019, 7:06am |
|
@storminvestor Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/W3X6wKPex4 #markets June 22nd 2019, 6:06am |
|
@TheMarketsDaily Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/5A4lrq1Z29 June 22nd 2019, 6:06am |
|
@stocknewstimes Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/QpxerUNvOd June 22nd 2019, 6:06am |
|
@SleekMoneycom Zacks Investment Research Lowers Celsion $CLSN to Sell https://t.co/Dk21JsG9gI #investing June 22nd 2019, 6:06am |
 |
@MaisaCorp $CLSN Celsion to Start Dutch Trial of Drug in Combo with Ultrasound Therapy for Breast Cancer Patients June 20th 2019, 4:06pm |
 |
@StockNewsNow $CLSN Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox® Plus High Intensity Focused Ultrasound… https://t.co/jrapx5OX6t June 20th 2019, 12:06pm |
 |
@ToothFrank Celsion ( $CLSN ) said Thursday that the University Medical Center Utrecht in the Netherlands has obtained Insti… https://t.co/8vWg78zCKA June 20th 2019, 10:06am |
 |
@NewsQuantified $CLSN announces that the University Medical Center Utrecht in the Netherlands has received Institutional Review Bo… https://t.co/gn4EZ4QHnz June 20th 2019, 9:06am |
 |
@NewsToDesk $CLSN: Celsion +13% premarket on IRB approval for ThermoDox + MR …: https://t.co/qnlmInPnJk June 20th 2019, 9:06am |
 |
@MarketCurrents $CLSN - Celsion +13% premarket on IRB approval for ThermoDox + MR-HIFU study https://t.co/BvprJeBvP6 June 20th 2019, 8:06am |
 |
@ez_alertz $CLSN Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox Plus High Intensity Focused Ultrasound… https://t.co/Pc4WG6uxmd June 20th 2019, 8:06am |
 |
@bthefirsttoknow $CLSN Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox(R) Plus High Intensity Focused Ultrasou… https://t.co/Uvqdmo6b7F June 20th 2019, 8:06am |
 |
@Allstocknews $CLSN Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox® Plus High Intensity Focused Ultr From our Stock News Alerts App June 20th 2019, 8:06am |
|
@TickerReport Celsion $CLSN Downgraded by Zacks Investment Research https://t.co/d507UVm50M June 19th 2019, 8:06pm |
 |
@InsiderAlertsIA $CLSN: New Insider Filing on CFO JEFFREY WAYNE CHURCH: https://t.co/l4G9MAKu1M June 19th 2019, 12:06pm |
 |
@fintel_io Insider CHURCH JEFFREY WAYNE reports buying 5,000 shares of $CLSN for a total cost of $9,450.00 https://t.co/31Tz0830lG June 19th 2019, 12:06pm |
 |
@LargeVoidBot $CLSN Jun 19, CFO Buys 5000 Shrs; Net: 9.45k; Acq'd: 5000 1.89/s; Disp'd: 0 https://t.co/RCgNPYG87w June 19th 2019, 12:06pm |
|
@SolarMelt $CLSN Positive MACD Crossover. If it's gunna run, now's about the time. First Interim Efficacy Analysis due in Q3.… https://t.co/4e31DxNff3 June 18th 2019, 9:06pm |
 |
@signaljumper $CLSN i m a buyer here June 17th 2019, 2:06pm |
 |
@StockSpotter $CLSN up 0.8% to 1.81 after our bullish setup alert Thu. Jun 13 after the close #swingtrading https://t.co/w9AveADkQ7 June 14th 2019, 10:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.